Diagnósticos da América S.A. (DASA3) Earnings Call Transcripts

Diagnósticos da América S.A.'s Latest Earnings Call - Q4 FY2025

Diagnósticos da América S.A. (DASA) reported its Q4 2025 and full-year results, highlighting a strategic shift towards diagnostics and efficiency. Revenue for the quarter grew by 13.3% YoY, driven by a 16% increase in exam volumes, while full-year revenue increased by 9.6%. The company achieved a recurring EBITDA of BRL 400 million for the quarter, marking a 21% YoY growth, despite significant non-recurring impacts. Management maintained a positive outlook for 2026, emphasizing operational improvements and cash generation.

Reported metrics

Guidance from management

Management maintained a positive outlook for 2026, emphasizing continued revenue growth and margin expansion. They highlighted operational improvements and cash generation as key focus areas.

What management said

This is Lucchesi. Leandro, I would like to refer to the operations of hospitals in Northeast. Well, what is happening there is what we desired an operational advance in operations in revenues and margin, we have spoken about the change of mix of operators with positive results and advance vis-a-vis the same quarter last year, a reduction of cancellations that had an important impact last year. All of these line items...

Samuel, this is Bossolani. Now regarding that information on assets that went from the JV back to our mail, this is a small business, highly specialized, focused on maternities and that alternatively could work better in a vertical network this didn't make sense for the joint venture. Once again, it's a small business. And looking forward, it will contribute positively to the results of the debt, it's a business wit...

What analysts pressed on

Analysts expressed concerns about the increase in net debt of Rede Americas and the impact of non-recurring items on the financial results. Questions were raised about the potential for further asset sales and the company's strategy for deleveraging.

Main topics on the call

• Revenue Growth — DASA reported a 13.3% YoY increase in Q4 2025 revenue, primarily driven by a 16% increase in exam volumes. The growth was diversified across B2B, home care, and premium segments. Management noted, 'We continue to increas...
• Margin Expansion — The company achieved a 50 basis point increase in quarterly margins and a 60 basis point increase for the year, attributed to productivity gains and cost control. 'We had a gain of 50 basis points in the quarter and 60 f...
• Deleveraging Efforts — DASA reduced its leverage from 4x to 2.67x EBITDA by year-end, meeting its deleveraging guidance. Management highlighted, 'We ended the year with a relevant reduction in the company leverage going from 4x in the fourth q...
• Non-Recurring Impacts — The quarter was impacted by non-recurring items, including a BRL 200 million accounting adjustment related to Rede Americas and a BRL 400 million write-down from the sale of Hospital Santa Lucia. 'This is a nonrecurring ...

Read the full Diagnósticos da América S.A. transcript (Q4 FY2025) → Summary generated from the call transcript; every figure above is stated by management on the record.

Earnings Call History

EarningsCalls.dev has 17 Diagnósticos da América S.A. earnings call transcripts on record, spanning May 13, 2022 to May 13, 2026. Based on this history, Diagnósticos da América S.A. reports quarterly. The most recent call on file is dated May 13, 2026. The full list is below — each row opens the complete, free-to-read transcript.

Ticker

DASA3

Exchange

BOVESPA

Country

BR

Sector

Health Care

Industry

Health Care Providers and Services

Calls on record

17

First call

May 13, 2022

Most recent

May 13, 2026

Reporting cadence

quarterly